CytoMed Therapeutics Limited
GDTCNASDAQHealthcare● Active
$1.07
$-0.09(-7.39%)
Market Cap$12601969
P/E Ratio—
52W High$3.68
52W Low$0.68
CytoMed Therapeutics Limited（GDTC）· 资产负债表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · GDTC · 截至 2026-06-10
财务报表
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $2.10M | $4.97M | $9.02M | $1.59M | $2.53M |
| Net Receivables | $0.13M | $0.02M | $0.00M | $0.00M | $0.00M |
| Inventory | $0.00M | $0.84M | $0.68M | $0.58M | $0.43M |
| Total Current Assets | $3.66M | $6.00M | $10.12M | $2.51M | $3.29M |
| PP&E Net | $3.69M | $3.25M | $2.07M | $2.49M | $2.50M |
| Goodwill | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Intangible Assets | $0.12M | $0.09M | $0.01M | $0.02M | $0.03M |
| Total Assets | $7.98M | $10.07M | $12.40M | $5.25M | $6.10M |
| Liabilities | |||||
| Short-Term Debt | $0.04M | $0.04M | $0.03M | $3.75M | $2.70M |
| Accounts Payable | $0.12M | $0.04M | $0.02M | $0.01M | $0.05M |
| Total Current Liabilities | $0.71M | $0.61M | $0.72M | $4.18M | $2.94M |
| Long-Term Debt | $0.37M | $0.39M | $0.41M | $0.47M | $0.54M |
| Total Liabilities | $1.13M | $1.02M | $1.13M | $4.66M | $3.50M |
| Stockholders Equity | |||||
| Retained Earnings | ($18.83M) | ($14.84M) | ($12.37M) | ($8.24M) | ($5.08M) |
| Total Stockholders Equity | $6.54M | $8.96M | $11.28M | $0.59M | $2.60M |
| Total Liab & Equity(computed) | $7.68M | $9.99M | $12.40M | $5.25M | $6.10M |
| Debt Summary | |||||
| Total Debt | $0.48M | $0.46M | $0.45M | $4.24M | $3.27M |
| Net Debt | ($1.61M) | ($4.51M) | ($8.57M) | $2.65M | $0.75M |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · SGD · M
深入了解CytoMed Therapeutics Limited
关于CytoMed Therapeutics Limited（GDTC）资产负债表
CytoMed Therapeutics Limited总资产$0.01B，现金及短期投资$0.00B，总负债$0.00B，总债务$0.00B，股东权益$0.01B。
常见问题
GDTC · 4 问CytoMed Therapeutics Limited总债务$0.00B，净债务($0.00B)。
GDTC total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10